Literature DB >> 16360447

Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.

J M Chan1, E P Elkin, S J Silva, J M Broering, D M Latini, P R Carroll.   

Abstract

OBJECTIVES: To assess specific complementary and alternative medicine (CAM) use in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a large, community-based national registry of men with prostate cancer.
METHODS: We examined more than 50 types of CAM use in a large, national, community-based registry of men with prostate cancer (CaPSURE). Participants completed biannual surveys within 2 years of diagnosis and treatment. We analyzed associations of CAM use with sociodemographic and clinical features, using chi-square tests and multivariate logistic regression.
RESULTS: One third of 2582 respondents reported using CAM. Common practices included vitamin and mineral supplements (26%), herbs (16%), antioxidants (13%), and CAM for prostate health (12%; eg, saw palmetto, selenium, vitamin E, lycopene). In multivariate analyses, users were more likely to have other comorbid conditions, worse cancer grade at diagnosis, higher incomes, more education, and to live in the West.
CONCLUSIONS: Complementary and alternative medicine use was associated with sociodemographic and clinical characteristics in this large sample of men with prostate cancer. These results should be considered by health care professionals counseling men with prostate cancer regarding diet and secondary prevention.

Entities:  

Mesh:

Year:  2005        PMID: 16360447     DOI: 10.1016/j.urology.2005.06.003

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  21 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

2.  Use of complementary and alternative medicine among men with prostate cancer in a rural setting.

Authors:  Susan Butler; Ashli Owen-Smith; Colleen DiIorio; Michael Goodman; Jonathan Liff; Kyle Steenland
Journal:  J Community Health       Date:  2011-12

3.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

4.  Nutraceuticals in Prostate Disease: The Urologist's Role.

Authors:  J Curtis Nickel; Daniel Shoskes; Claus G Roehrborn; Mark Moyad
Journal:  Rev Urol       Date:  2008

5.  Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey.

Authors:  F Patricia McEachrane-Gross; Jane M Liebschutz; Dan Berlowitz
Journal:  BMC Complement Altern Med       Date:  2006-10-06       Impact factor: 3.659

6.  [Importance of complementary medicine approaches for patients with prostate cancer].

Authors:  K M Gschwendtner; G Klein; C Güthlin; C Holmberg; M Horneber; J Weis
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

7.  Use of complementary medications among older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Kayo Togawa; William P Tew; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Stuart M Lichtman; Ajeet Gajra; Rupal Ramani; Vani Katheria; Shira M Klapper; Kurt Hansen; Arti Hurria
Journal:  Cancer       Date:  2012-02-22       Impact factor: 6.860

8.  Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients.

Authors:  Susanne Sarkar; Leon Sautier; Georgia Schilling; Carsten Bokemeyer; Uwe Koch; Anja Mehnert
Journal:  J Cancer Surviv       Date:  2015-02-13       Impact factor: 4.442

9.  Complementary and alternative therapies for urinary symptoms: use in a diverse population sample qualitative study.

Authors:  Courtney B Jackson; Simone P Taubenberger; Elizabeth Botelho; Journel Joseph; Sharon L Tennstedt
Journal:  Urol Nurs       Date:  2012 May-Jun

10.  Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load.

Authors:  Nina Pauline Holzapfel; Ali Shokoohmand; Ferdinand Wagner; Marietta Landgraf; Simon Champ; Boris Michael Holzapfel; Judith Ann Clements; Dietmar Werner Hutmacher; Daniela Loessner
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.